These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16260749)

  • 21. HIV-1 Tat protein-mediated transactivation of the HIV-1 long terminal repeat promoter is potentiated by a novel nuclear Tat-interacting protein of 110 kDa, Tip110.
    Liu Y; Li J; Kim BO; Pace BS; He JJ
    J Biol Chem; 2002 Jun; 277(26):23854-63. PubMed ID: 11959860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat.
    Cheng H; Tarnok J; Parks WP
    J Virol; 1998 Aug; 72(8):6911-6. PubMed ID: 9658145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.
    Rhim H; Rice AP
    Nucleic Acids Res; 1994 Oct; 22(21):4405-13. PubMed ID: 7971271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine.
    Jiang MC; Lin JK; Chen SS
    Biochem Biophys Res Commun; 1996 Sep; 226(1):1-7. PubMed ID: 8806583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.
    Harhaj E; Blaney J; Millhouse S; Sun SC
    Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
    Agbottah E; Deng L; Dannenberg LO; Pumfery A; Kashanchi F
    Retrovirology; 2006 Aug; 3():48. PubMed ID: 16893449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
    Tiley LS; Madore SJ; Malim MH; Cullen BR
    Genes Dev; 1992 Nov; 6(11):2077-87. PubMed ID: 1427073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic HIV-1 Tat can dissociate HeLa nuclear protein-TAR RNA complexes in vitro: a novel Tat-nuclear protein interaction.
    Jeyapaul J; Seshamma T; Khan SA
    Oncogene; 1991 Sep; 6(9):1507-13. PubMed ID: 1923518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5.
    Ping YH; Chu CY; Cao H; Jacque JM; Stevenson M; Rana TM
    Retrovirology; 2004 Dec; 1():46. PubMed ID: 15620346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
    García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB
    J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
    Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
    Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription.
    Nekhai S; Zhou M; Fernandez A; Lane WS; Lamb NJ; Brady J; Kumar A
    Biochem J; 2002 Jun; 364(Pt 3):649-57. PubMed ID: 12049628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
    Roebuck KA; Rabbi MF; Kagnoff MF
    AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells.
    Alonso A; Derse D; Peterlin BM
    J Virol; 1992 Jul; 66(7):4617-21. PubMed ID: 1602563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells.
    Kelly GD; Morris CB; Offermann MK
    Virology; 1999 Oct; 263(1):128-38. PubMed ID: 10544088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. I-mfa domain proteins specifically interact with HTLV-1 Tax and repress its transactivating functions.
    Kusano S; Yoshimitsu M; Hachiman M; Ikeda M
    Virology; 2015 Dec; 486():219-27. PubMed ID: 26469549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
    Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
    J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
    Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
    J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.